Philip J. Titcombe

813 total citations
14 papers, 367 citations indexed

About

Philip J. Titcombe is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Rheumatology. According to data from OpenAlex, Philip J. Titcombe has authored 14 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 5 papers in Rheumatology. Recurrent topics in Philip J. Titcombe's work include Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (7 papers) and Systemic Lupus Erythematosus Research (4 papers). Philip J. Titcombe is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (7 papers) and Systemic Lupus Erythematosus Research (4 papers). Philip J. Titcombe collaborates with scholars based in United States, Sweden and United Kingdom. Philip J. Titcombe's co-authors include Daniel L. Mueller, Vivianne Malmström, Lena Israelsson, Justin J. Taylor, Marc K. Jenkins, Ryan J. Martinez, Na Zhang, Stephanie R. Thomas, Khaled Amara and Shoshana D. Katzman and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Philip J. Titcombe

14 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip J. Titcombe United States 10 170 137 135 61 30 14 367
Justin H. Fransen Netherlands 10 292 1.7× 42 0.3× 135 1.0× 94 1.5× 32 1.1× 13 450
Michele Smart United States 12 219 1.3× 53 0.4× 47 0.3× 72 1.2× 29 1.0× 22 346
Signy Bendiksen Norway 10 161 0.9× 60 0.4× 173 1.3× 60 1.0× 39 1.3× 12 392
Jane A. McCutcheon United States 8 292 1.7× 55 0.4× 77 0.6× 46 0.8× 10 0.3× 12 387
C Pummerer Austria 11 298 1.8× 83 0.6× 47 0.3× 87 1.4× 22 0.7× 12 602
Sarah Casulli France 11 168 1.0× 30 0.2× 68 0.5× 113 1.9× 28 0.9× 11 398
Rick TH Ong Singapore 4 83 0.5× 55 0.4× 147 1.1× 83 1.4× 21 0.7× 5 403
Erinn S. Kellner United States 7 343 2.0× 23 0.2× 178 1.3× 98 1.6× 22 0.7× 11 477
Édgar Garavito Colombia 8 303 1.8× 33 0.2× 86 0.6× 87 1.4× 44 1.5× 9 509
M Stempniak United States 8 139 0.8× 126 0.9× 87 0.6× 153 2.5× 15 0.5× 10 357

Countries citing papers authored by Philip J. Titcombe

Since Specialization
Citations

This map shows the geographic impact of Philip J. Titcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Titcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Titcombe more than expected).

Fields of papers citing papers by Philip J. Titcombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Titcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Titcombe. The network helps show where Philip J. Titcombe may publish in the future.

Co-authorship network of co-authors of Philip J. Titcombe

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Titcombe. A scholar is included among the top collaborators of Philip J. Titcombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Titcombe. Philip J. Titcombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Titcombe, Philip J., et al.. (2023). BATF represses BIM to sustain tolerant T cells in the periphery. The Journal of Experimental Medicine. 220(12). 9 indexed citations
2.
Thomas, Stefani N., Kathryn A. Pape, Jennifer M. Peters, et al.. (2021). Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA. Clinical Biochemistry. 90. 15–22. 11 indexed citations
3.
Sahlström, Peter, Monika Hansson, Johanna Stéen, et al.. (2020). Different Hierarchies of Anti–Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis. Arthritis & Rheumatology. 72(10). 1643–1657. 52 indexed citations
4.
Thomas, Stefani N., Kathryn A. Pape, Jennifer M. Peters, et al.. (2020). Initial Determination of COVID-19 Seroprevalence Among Outpatients and Healthcare Workers in Minnesota Using a Novel SARS-CoV-2 Total Antibody ELISA. SSRN Electronic Journal. 2 indexed citations
5.
Titcombe, Philip J., Gustaf Wigerblad, Natalie Sippl, et al.. (2018). Pathogenic Citrulline‐Multispecific B Cell Receptor Clades in Rheumatoid Arthritis. Arthritis & Rheumatology. 70(12). 1933–1945. 52 indexed citations
6.
Krishnamurthy, Akilan, Katalin Sándor, Alexandra Jurczak, et al.. (2018). P001 Mechanisms of bone erosion and pain triggered by antibodies targeting post-translational protein modifications in rheumatoid arthritis. Annals of the Rheumatic Diseases. 77. A14–A14. 1 indexed citations
7.
Lloyd, Katy A., Johanna Stéen, Khaled Amara, et al.. (2018). Variable domain N‐linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B‐cell selection. European Journal of Immunology. 48(6). 1030–1045. 34 indexed citations
8.
Amara, Khaled, Lorraine Yeo, Daniel Ramsköld, et al.. (2017). B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis. Journal of Autoimmunity. 81. 34–43. 45 indexed citations
9.
Amara, Khaled, Lorraine Yeo, Daniel Ramsköld, et al.. (2017). Immunoglobulin characteristics and RNAseq data of FcRL4+ B cells sorted from synovial fluid and tissue of patients with rheumatoid arthritis. Data in Brief. 13. 356–370. 2 indexed citations
10.
Joshua, Vijay, Philip J. Titcombe, Lena Israelsson, et al.. (2016). Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells. Arthritis Research & Therapy. 18(1). 284–284. 20 indexed citations
11.
Laudenbach, Megan, Federico Baruffaldi, Mark D. Distefano, et al.. (2015). The Frequency of Naive and Early-Activated Hapten-Specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse. The Journal of Immunology. 194(12). 5926–5936. 32 indexed citations
12.
Haasken, Stefanie, Jennifer L. Auger, Justin J. Taylor, et al.. (2013). Macrophage Scavenger Receptor 1 (Msr1, SR-A) Influences B Cell Autoimmunity by Regulating Soluble Autoantigen Concentration. The Journal of Immunology. 191(3). 1055–1062. 11 indexed citations
13.
Titcombe, Philip J., et al.. (2013). Detection and characterization of autoreactive B cells in patients with Rheumatoid Arthritis (P4024). The Journal of Immunology. 190(Supplement_1). 42.13–42.13. 1 indexed citations
14.
Taylor, Justin J., Ryan J. Martinez, Philip J. Titcombe, et al.. (2012). Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. The Journal of Experimental Medicine. 209(11). 2065–2077. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026